Showing results (391-400 of 480) with videos related to
Sort By:
Pageof 48
Human Vaccines & Immunotherapeutics|March 3, 2023
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factorsLaura L Hammitt, Dean Quinn, Ewa Janczewska, et al.Hepatology Communications|February 23, 2026
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosisAmit G Singal, Qingchun Jin, Jorge Marrero, et al.Gut|July 15, 2020
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohortJasmohan S Bajaj, Guadalupe Garcia-Tsao, Scott W Biggins, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2019
Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organPaige M Porrett, Peter P Reese, Vera Holzmayer, et al.Plos One|August 2, 2018
A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational studyDonna M Evon, Paul W Stewart, Jipcy Amador, et al.The American Journal of Gastroenterology|January 30, 2019
Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial PeritonitisJasmohan S Bajaj, Puneeta Tandon, Jacqueline G OʼLeary, et al.Hepatology (Baltimore, Md.)|October 20, 2012
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trialMark S Sulkowski, Fred Poordad, Michael P Manns, et al.Hepatology (Baltimore, Md.)|April 17, 2020
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus StatementOren K Fix, Bilal Hameed, Robert J Fontana, et al.Journal of Clinical and Experimental Hepatology|July 31, 2019
Strategy and Efficacy of Generic and Pan-genotypic Sofosbuvir/Velpatasvir in Chronic Hepatitis C Virus: A Myanmar ExperienceAung H Bwa, Gayatri Nangia, Si T S Win, et al.The New England Journal of Medicine|March 3, 2021
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal SyndromeFlorence Wong, S Chris Pappas, Michael P Curry, et al.Pageof 48